Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, openWorld, idempotent, and non-destructive behavior, so the bar is for additional context. The description adds substantial behavior: it cascades through multiple endpoints, degrades gracefully if GLEIF/OpenFIGI are unavailable (EDGAR still returns), labels each identifier with its source, explicitly lists unresolved identifiers rather than omitting them, and asserts nothing when conflicts arise (returning figi_candidates). This goes well beyond the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but densely informative. It is front-loaded with usage examples and immediately states the core purpose. While it could be tightened, every sentence serves a purpose: explaining supported types, input rules, fallback behavior, and output semantics. The structure uses paragraphs and examples effectively, though it remains a wall of text without bullet points.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple identifier sources, fallback scenarios), the description is exceptionally complete. It covers input formats, edge cases (non-equity instruments, ISIN-to-LEI mapping), graceful degradation, duplicate-match handling, and the explicit 'unresolved' field. It also communicates that enrichment is optional and EDGAR identifiers always return. No missing information needed for correct invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% (both 'type' and 'value' have descriptions), so the baseline is 3. The description adds significant extra meaning: it explains the exact accepted formats (ticker, CIK, ISIN, name for company; brand/generic for drug), provides specific examples ('AAPL', '0000320193', 'ozempic'), and clarifies the critical pitfall for bonds (pass issuer only, not the full instrument phrase). This goes far beyond the schema's simple field descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with clear example queries and states 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It specifies the verb (resolve), resource (entity names), and output (identifiers), and differentiates from sibling tools by positioning it as the first-step lookup for IDs. It also clearly delineates the two supported entity types (company, drug).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly instructs 'Use FIRST whenever you have a name but need an ID,' establishing priority and context. It provides detailed guidance on input formats for companies (ticker, CIK, name) and drugs (brand/generic), and includes edge-case instructions like passing the bond issuer exactly as printed rather than the full noun phrase. It also notes that it replaces 2-3 manual lookups, clarifying its role.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

The four card tools are distinct, but the majority of the server is a Pipeworx/prediction-market platform with heavily overlapping entry points: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and discover_tools all serve similar query/discovery purposes, and ask_pipeworx_beta is explicitly an identical twin of ask_pipeworx. The six Polymarket tools and the ai_visibility/scan_competitor pair also have fuzzy boundaries that would make tool selection error-prone.

Naming Consistency2/5

All names are snake_case, but the pattern is highly inconsistent: some are verb_noun (get_card, search_cards, resolve_entity), some are bare verbs (remember, forget), some are noun-first (polymarket_edges, entity_profile, bet_research), and some are adjective_noun (recent_alerts, recent_changes). The ask_pipeworx variants share a name but differ only by suffix, which is not a clear action-oriented pattern.

Tool Count2/5

35 tools is squarely in the 'too many' territory, and the bloat is worse because the server is named Tcgdex while only 4 of 35 tools actually relate to trading cards. The remaining 31 tools form a sprawling multi-domain platform that mixes data queries, prediction markets, memory, subscriptions, AI visibility checks, and one-off utilities like generate_llms_txt and scan_dependency.

Completeness4/5

For the TCGdex card surface, the read-only workflows are covered well: search_cards leads to get_card, and list_sets leads to get_set, with no obvious dead ends. For the broader Pipeworx functionality, the set includes discovery, query, grounding, entity resolution, memory, subscriptions, and feedback, so the main workflows are supported—though the overall scope is sprawling rather than focused.